Negotiation Training
Since 2011, the early benefit evaluation of new drugs has been a major challenge for pharmaceutical companies. The purpose of early benefit assessment is to negotiate prices for reimbursement amounts. The AMNOG process requires different negotiation skills and abilities are required in order to optimally design the process.
We offer trainings to prepare for:
- The G-BA consultation for determining the appropriate comparative therapy and the considered patient-relevant outcomes;
- The Federal Joint Committee’s position and oral hearing as part of the benefit assessment and resolution;
- The actual price negotiations for the reimbursement amount with the GKV Spitzenverband.
- Profit from our experience to optimally prepare the content and communication for the important negotiations with the payers.
Benefit from our competence in content and negotiation theory.
European Reference Price Calculator
Drug prices in many countries are also determined by European reference prices. The result is a complex and interdependent system of mutual price referencing, so that price negotiations in one European country have an impact on prices in other countries. In Germany, a special algorithm applies in which prices and quantities are estimated according to purchasing power parity.
We have developed an iterative European reference price calculator with which you can simulate the price development on the basis of the reference price system over time. This allows you to define optimal launch sequences and predict the price development.
Use our European Reference Price Calculator to prepare your negotiations with the cost units by simulating and strategically applying the effects of different transfer prices on the respective countries.
Reference Price Calculator
For patent-free drugs, the reference amount system has been established in Germany in the last few years. In this system, a maximum reimbursement amount is determined on the basis of market prices as well as packaging and prescription shares by the G-BA and the GKV-Spitzenverband.
We support you in the G-BA’s comments procedure in determining new reference price groups.
You can use our reference amount calculator for your market strategy in order to simulate and calculate reference amounts fast and easy.